New Patented Medicines Reported to PMPRB

Up to date as of June 16, 2016

Search by:

to

* Note: Drugs with Price Review Records linked from the brand name are only available from 2010 onward (records for 2011 will be populated over the next few months). Summary Reports are available for drug products reported prior to 2010.


YearCompanyBrand NameChemical NameDINTherapeutic UseDate of First SaleStatus
2014Alcon Canada Inc.Ilevro - 3 mg/mlnepafenac02411393Pain6 Jul 2014Within Guidelines
2014Pfizer Canada Inc.Elelyso - 200 unit/vialtaliglucerase alfa02425637Gaucher disease8 Sep 2014Within Guidelines
2014Valeant Canada LpVyloma - 250 mg/pouchimiquimod02365561Genital warts9 Dec 2011 (patented 13 May 2014)Within Guidelines
2014Abbott Laboratories LimitedCreon Minimicrospheres - 6000 unit/capsulepancreatin02415194Pancreatic exocrine insufficiency22 Dec 2013Within Guidelines
2014Actavis Specialty Pharmaceuticals Co.Lolo 1/0.1 norethindrone acetate/ethinyl estradiol02417456Contraceptive24 Mar 2014Within Guidelines
2014Actavis Specialty Pharmaceuticals Co.Constella - 290 mcg/capsulelinaclotide02417162Irritable bowel syndrome27 Nov 2014Within Guidelines
2014Actavis Specialty Pharmaceuticals Co.Constella - 145 mcg/capsulelinaclotide02417162Irritable bowel syndrome1 May 2014Within Guidelines
2014Actavis Specialty Pharmaceuticals Co.Fibristal - 5 mg/tabletulipristal acetate02408163Selective Progesterone Receptor Modulator04 Jul 2014Subject to Investigation
2014Actelion Phamaceuticals Canada Inc.Caripul - 0.5 mg/vialepoprostenol sodium02397447Hypertension24 Apr 2014 (patented 16 Dec 2014)Within Guidelines
2014Actelion Phamaceuticals Canada Inc.Caripul - 1.5 mg/vialepoprostenol sodium02397455Hypertension24 Apr 2014 (patented 16 Dec 2014)Within Guidelines
2014Actelion Phamaceuticals Canada Inc.Xiaflex - 0.9 mg/vialcollagenase clostridium histolyticum02388316Dupuytren’s contracture15 Apr 2013 (patented 19 Aug 2014)Within Guidelines
2014Actelion Phamaceuticals Canada Inc.Opsumit - 10 mg/tabletmacitentan02415690Pulmonary arterial hypertension15 Jan 2014Within Guidelines
2014Aegerion Pharmaceuticals (Canada) Ltd.Juxtapid - 5 mg/capsulelomitapide02420341Microsomal Triglyceride Transfer Protein Inhibitor6 May 2014Within Guidelines
2014Aegerion Pharmaceuticals (Canada) Ltd.Juxtapid - 10 mg/capsulelomitapide02420376Microsomal Triglyceride Transfer Protein Inhibitor6 May 2014Within Guidelines
2014Aegerion Pharmaceuticals (Canada) Ltd.Juxtapid - 20 mg/capsulelomitapide02420384Microsomal Triglyceride Transfer Protein Inhibitor6 May 2014Within Guidelines
2014AstraZeneca Canada Inc.FluMist Quadrivalent - 0.2 unit/doseinfluenza vaccine02426544Influenza10 Oct 2014Within Guidelines
2014Bayer Inc.Xofigo - 1000 kilobecquerel/mlradium Ra 223 dichlorideProstate Cancer29 Aug 2014Within Guidelines
2014Bayer Inc.Eylea - 40 mg/mlaflibercept02415992Neovascular (wet) age-related macular degeneration23 Dec 2013Within Guidelines
2014Biogen Idec Canada Inc.Tecfidera - 240 mg/capsuledimethyl fumarate02420201Multiple sclerosis5 May 2014Subject to Investigation
2014Boehringer Ingelheim (Canada) Ltd.Giotrif - 20 mg/tabletafatinib02415666Protein Kinase Inhibitor17 Jan 2014Within Guidelines
2014Boehringer Ingelheim (Canada) Ltd.Giotrif - 30 mg/tabletafatinib02415674Protein Kinase Inhibitor17 Jan 2014Within Guidelines
2014Boehringer Ingelheim (Canada) Ltd.Giotrif - 40 mg/tabletafatinib02415682Protein Kinase Inhibitor17 Jan 2014Within Guidelines
2014Celgene Inc.Pomalyst - 1 mg/capsulepomalidomide02419580Multiple myeloma21 Feb 2014Within Guidelines
2014Celgene Inc.Pomalyst - 2 mg/capsulepomalidomide02419599Multiple myeloma21 Feb 2014Within Guidelines
2014Celgene Inc.Pomalyst - 3 mg/capsulepomalidomide02419602Multiple myeloma21 Feb 2014Within Guidelines
2014Celgene Inc.Pomalyst - 4 mg/capsulepomalidomide02419610Multiple myeloma26 Feb 2014Within Guidelines
2014Celgene Inc.Istodax - 10 mg/vialromidepsin02414295Peripheral T-cell lymphoma3 Apr 2014Within Guidelines
2014Ferring Pharmaceuticals Inc.Nocdurna - 50 mcg/tabletdesmopressin acetate02431076Nocturia17 Nov 2014Within Guidelines
2014Galderma Canada Inc.Onreltea - 5 mg/gbrimonidine02421208Rosacea24 Mar 2014Subject to Investigation
2014GenMedGD-Quinapril - 40 mg/tabletquinapril02291010Hypertension2 Jun 2014Within Guidelines
2014GenMedGD-Celecoxib - 100 mg/capsulecelecoxib02291975Arthritis20 Nov 2014Within Guidelines
2014GenMedGD-Celecoxib - 200 mg/capsulecelecoxib02291983Arthritis20 Nov 2014Within Guidelines
2014GenMedGD-Quinapril - 5 mg/tabletquinapril02290987Hypertension2 Jun 2014Within Guidelines
2014GenMedGD-Quinapril - 10 mg/tabletquinapril02290995Hypertension2 Jun 2014Within Guidelines
2014GenMedGD-Quinapril - 20 mg/tabletquinapril02291002Hypertension2 Jun 2014Within Guidelines
2014GenMedGD-Azithromycin - 20 mg/mlazithromycin02274566Antibiotic9 Dec 2013Within Guidelines
2014GenMedGD-Azithromycin - 40 mg/mlazithromycin02274574Antibiotic9 Dec 2013Within Guidelines
2014Gilead Sciences Inc.Harvoni 90/400 - 490 mg/tabletledipasvir/sofosbuvir02432226Hepatitis C16 Oct 2014Within Guidelines
2014Gilead Sciences Inc.Sovaldi - 400 mg/tabletsofosbuvir02418355Chronic hepatitis C virus6 Jan 2014Within Guidelines
2014Glaxosmithkline Inc.Rotarix - 1 n.a./doserotavirus vaccine02300591Vaccine17 Dec 2008 (patented 8 July 2014)Within Guidelines
2014Glaxosmithkline Inc.Anoro Ellipta 62.5/25 - 87.5 mcg/doseumeclidinium bromide/vilanterol02418401Chronic obstructive pulmonary disease14 Mar 2014Within Guidelines
2014Hoffmann-La Roche Limited, CanadaActemra 162 mg/syringe tocilizumab02424770Rheumatoid Arthritis30 May 2014Within Guidelines
2014Hoffmann-La Roche Limited, CanadaGazyva - 25 mg/mLobinutuzumab02434806Leukemia28 Nov 2014Does Not Trigger Investigation
2014Janssen Inc.Imbruvica - 140 mg/capsuleibrutinib02434407Leukemia25 Nov 2014Within Guidelines
2014Janssen Inc.Invokana - 100 mg/tabletcanagliflozin02425483Diabetes4 Jun 2014Does Not Trigger Investigation
2014Janssen Inc.Nucynta Extended Release - 100 mg/tablettapentadol hydrochloride02415585Pain21 Apr 2014Within Guidelines
2014Janssen Inc.Nucynta Extended Release - 150 mg/tablettapentadol hydrochloride02415593Pain21 Apr 2014Within Guidelines
2014Janssen Inc.Nucynta Extended Release - 200 mg/tablettapentadol hydrochloride02415607Pain21 Apr 2014Within Guidelines
2014Janssen Inc.Nucynta Extended Release - 250 mg/tablettapentadol hydrochloride02415615Pain21 Apr 2014Within Guidelines
2014Janssen Inc.Nucynta Extended Release - 50 mg/tablettapentadol hydrochloride02415577Pain21 Apr 2014Within Guidelines
2014Janssen Inc.Simponi - 50 mg/vialgolimumab02417472Rheumatoid Arthritis30 Dec 2013Within Guidelines
2014Janssen Inc.Prezcobix 800/150 - 950 mg/tabletdarunavir/cobicistat02426501HIV29 Aug 2014Within Guidelines
2014Janssen Inc.Invokana - 300 mg/tabletcanagliflozin02425491Diabetes28 May 2014Within Guidelines
2014Lundbeck Canada Inc.Trintellix - 5 mg/tabletvortioxetine hydrobromide02432919Antidepressant27 Nov 2014Within Guidelines
2014Lundbeck Canada Inc.Trintellix - 10 mg/tabletvortioxetine hydrobromide02432927Antidepressant27 Nov 2014Within Guidelines
2014Lundbeck Canada Inc.Trintellix - 20 mg/tabletvortioxetine hydrobromide02432943Antidepressant27 Nov 2014Within Guidelines
2014Merck Canada Inc.Ragwitek - 12 unit/tabletStandardized Allergen Extract, Short Ragweed (Ambrosia artemisiifolia)02423723Allergy immunotherapy29 Apr 2014Within Guidelines
2014Merck Canada Inc.Posanol - 100 mg/tabletposaconazole02424622Antifungal Agent21 May 2014Does Not Trigger Investigation
2014Merck Canada Inc.Janumet XR 50/1000 - 1050 mg/tabletsitagliptin phosphate monohydrate/metformin hydrochloride02416794Diabetes15 Jan 2014Within Guidelines
2014Merck Canada Inc.Grastek - 2800 unit/tabletstandardized allergenic extract, timothy grass (pleum pratense)02418394Allergy Immunotherapy13 Jan 2014Within Guidelines
2014Merck Canada Inc.Posanol - 300 mg/vialposaconazole0242462Antifungal Agent24 Nov 2014Subject to Investigation
2014Novartis Pharmaceuticals Canada Inc.Bexsero - 1 n.a./dosemulticomponent meningococcal B vaccine02417030Vaccine25 Feb 2014Within Guidelines
2014Novartis Pharmaceuticals Canada Inc.Lucentis - 0.5 mg/doseranibizumab02425629Neovascular (wet) Age-Related Macular Degeneration18 Sep 2014Within Guidelines
2014Novartis Pharmaceuticals Canada Inc.Afinitor Disperz - 2 mg/tableteverolimus02425645Cancer28 Nov 2014Within Guidelines
2014Novartis Pharmaceuticals Canada Inc.Afinitor Disperz - 3 mg/tableteverolimus02425653Cancer28 Nov 2014Within Guidelines
2014Novartis Pharmaceuticals Canada Inc.Afinitor Disperz - 5 mg/tableteverolimus02425661Cancer28 Nov 2014Within Guidelines
2014Novartis Pharmaceuticals Canada Inc.Ultibro Breezhaler 110/50 - 160 mcg/capsuleindacaterol maleate/glycopyrronium bromide02418282Chronic obstructive pulmonary disease5 Mar 2014Within Guidelines
2014Novo Nordisk Canada Inc.Norditropin NordiFlex - 5 mg/pensomatropin02334852Growth hormone deficiency21 Aug 2014Within Guidelines
2014Novo Nordisk Canada Inc.Norditropin NordiFlex - 10 mg/pensomatropin02334860Growth hormone deficiency21 Aug 2014Within Guidelines
2014Novo Nordisk Canada Inc.Norditropin NordiFlex - 15 mg/pensomatropin02334879Growth hormone deficiency21 Aug 2014Within Guidelines
2014Otsuka Canada PharmaceuticalsAbilify Maintena - 300 mg/vialaripiprazole02320864Schizophrenia27 Mar 2014Within Guidelines
2014Otsuka Canada PharmaceuticalsAbilify Maintena - 400 mg/vialaripiprazole02420872Schizophrenia27 Mar 2014Within Guidelines
2014Paladin Labs Inc.Veregen - 100 mg/gsinecatechins02411849Genital warts4 Jul 2014Within Guidelines
2014Paladin Labs Inc.Antizol - 1 g/mLfomepizole02242980Antidote for ethylene glycol2 Nov 2006 (patented 10 Jun 2014)Subject to Investigation
2014Pfizer Canada Inc.Irinotecan - 20 mg/mlirinotecan hydrochloride trihydrate02410419Metastatic colorectal cancer11 Mar 2014Subject to Investigation
2014Pfizer Canada Inc.Bosulif - 100 mg/tabletbosutinib02419149Protein-tyrosine kinase inhibitor31 Mar 2014Within Guidelines
2014Pfizer Canada Inc.Bosulif - 500 mg/tabletbosutinib02419157Protein-tyrosine kinase inhibitor31 Mar 2014Within Guidelines
2014Pfizer Canada Inc.Cytarabine - 100 mg/mlcytarabine02406772Leukemia17 Jan 2014Within Guidelines
2014Pfizer Canada Inc.Cytarabine - 20 mg/mlcytarabine02406764Leukemia17 Jan 2014Within Guidelines
2014Pfizer Canada Inc.Xeljanz - 5 mg/tablettofacitinib02423898Rheumatoid arthritis6 Jun 2014Within Guidelines
2014Sanofi-Aventis Canada Inc.Zaltrap - 200 mg/vialaflibercept02421089Metastatic colorectal cancer8 May 2014Within Guidelines
2014Sanofi-Aventis Canada Inc.Zaltrap - 100 mg/vialaflibercept02421070Metastatic colorectal cancer8 May 2014Within Guidelines
2014Sunovion Pharmaceuticals Canada Inc.Latuda - 20 mg/tabletlurasidone hydrochloride02422050Schizophrenia29 Apr 2014Within Guidelines
2014Sunovion Pharmaceuticals Canada Inc.Aptiom - 200 mg/tableteslicarbazepine acetate02426862Epilepsy9 Oct 2014Within Guidelines
2014Sunovion Pharmaceuticals Canada Inc.Aptiom - 400 mg/tableteslicarbazepine acetate02426870Epilepsy9 Oct 2014Within Guidelines
2014Sunovion Pharmaceuticals Canada Inc.Aptiom - 600 mg/tableteslicarbazepine acetate02426889Epilepsy9 Oct 2014Within Guidelines
2014Sunovion Pharmaceuticals Canada Inc.Aptiom - 800 mg/ tableteslicarbazepine acetate02426897Epilepsy9 Oct 2014Within Guidelines
2014Sunovion Pharmaceuticals Canada Inc.Latuda - 60 mg/tabletlurasidone hydrochloride02413361Schizophrenia14 Mar 2014Within Guidelines
2014Takeda Canada Inc.Nesina - 12.5 mg/tabletalogliptin benzoate02417197Diabetes30 Apr 2014Within Guidelines
2014Takeda Canada Inc.Nesina - 25 mg/tabletalogliptin benzoate02417200Diabetes30 Apr 2014Within Guidelines
2014Takeda Canada Inc.Nesina - 6.25 mg/tabletalogliptin benzoate02417189Diabetes30 Apr 2014Within Guidelines
2014Takeda Canada Inc.Kazano 12.5/1000 - 1012.5 mg/tabletalogliptin benzoate/metformin hydrochloride02417235Diabetes30 Apr 2014Within Guidelines
2014Takeda Canada Inc.Kazano 12.5/500 - 512.5 mg/tabletalogliptin benzoate/metformin hydrochloride02417219Diabetes30 Apr 2014Within Guidelines
2014Takeda Canada Inc.Kazano 12.5/850 - 862.5 mg/tabletalogliptin benzoate/metformin hydrochloride02417227Diabetes30 Apr 2014Within Guidelines
2014Teva Canada InnovationFentora - 100 mcg/tabletfentanyl citrate02408007Pain14 May 2014Within Guidelines
2014Teva Canada InnovationFentora - 200 mcg/tabletfentanyl citrate02408015Pain14 May 2014Within Guidelines
2014Teva Canada InnovationFentora - 400 mcg/tabletfentanyl citrate02408023Pain14 May 2014Within Guidelines
2014Teva Canada InnovationFentora - 600 mcg/tabletfentanyl citrate02408031Pain14 May 2014Within Guidelines
2014Teva Canada InnovationFentora - 800 mcg/tabletfentanyl citrate02408058Pain14 May 2014Within Guidelines
2014UCB Canada Inc.Neupro - 1 mg/patchrotigotine02403897Parkinson’s disease (dopamine agonist)19 Dec 2013Within Guidelines
2014UCB Canada Inc.Neupro - 3 mg/patchrotigotine02403919Parkinson’s disease (dopamine agonist)19 Dec 2013Within Guidelines
2014Valeant Canada LpJublia - 100 mg/gefinaconazole02413388Antifungal agent21 Jul 2014Within Guidelines
2014ViiV Healthcare UlcTriumeq 50/600/300 – 950 mg/tabletdolutegravir/abacavir/lamivudine02430932HIV22 Oct 2014Within Guidelines